Long-Term Safety and Efficacy of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter, Open-Label, Phase II Study

被引：11
|
作者：
Song, Yuqin
Song, Yongping
Liu, Lihong
Zhang, Mingzhi
Li, Zhiming
Ji, Chunyan
Xu, Wei
Liu, Ting
Xu, Bing
Wang, Xin
Gao, Sujun
Zhang, Huilai
Hu, Yu
Li, Yan
Cheng, Ying
Yang, Haiyan
Cao, Junning
Zhu, Zunmin
Hu, Jianda
Zhang, Wei
Jing, Hongmei
Ding, Kaiyang
Lu, Zhengguang
Zhang, Bin
Zhao, Renbin
Xu, Zhixin
Zhu, Jun
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141781
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase study
    Dreyling, Martin
    Jurczak, Wojciech
    Jerkeman, Mats
    Silva, Rodrigo Santucci
    Rusconi, Chiara
    Trneny, Marek
    Offner, Fritz
    Caballero, Dolores
    Joao, Cristina
    Witzens-Harig, Mathias
    Hess, Georg
    Bence-Bruckler, Isabelle
    Cho, Seok-Goo
    Bothos, John
    Goldberg, Jenna D.
    Enny, Christopher
    Traina, Shana
    Balasubramanian, Sriram
    Bandyopadhyay, Nibedita
    Sun, Steven
    Vermeulen, Jessica
    Rizo, Aleksandra
    Rule, Simon
    LANCET, 2016, 387 (10020): : 770 - 778
  • [32] Ofatumumab monotherapy in relapsed/refractory mantle cell lymphoma - a phase II trial
    Furtado, Michelle
    Dyer, Martin J. S.
    Johnson, Rod
    Berrow, Margie
    Rule, Simon
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (04) : 575 - 578
  • [33] Long-term Safety and Efficacy of Etanercept in Patients With Psoriasis: An Open-label Study
    Leonardi, Craig
    Strober, Bruce
    Gottlieb, Alice B.
    Elewski, Boni E.
    Ortonne, Jean-Paul
    van de Kerkhof, Peter
    Chiou, Chiun-Fang
    Dunn, Meleana
    Jahreis, Angelika
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (08) : 928 - 937
  • [34] An Open-Label Phase II Study of Buparlisib (BKM120) in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma or Follicular Lymphoma
    Younes, Anas
    Salles, Gilles
    Bociek, R. Gregory
    Martinelli, Giovanni
    Caballero, Dolores
    Gonzalez Barca, Eva
    Mukherjee, Nabanita
    Williams, Lisa
    Herbst, Fabian
    Tavorath, Ranjana
    Kim, Won Seog
    BLOOD, 2014, 124 (21)
  • [35] Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma
    Shi, Y.
    Dong, M.
    Hong, X.
    Zhang, W.
    Feng, J.
    Zhu, J.
    Yu, L.
    Ke, X.
    Huang, H.
    Shen, Z.
    Fan, Y.
    Li, W.
    Zhao, X.
    Qi, J.
    Huang, H.
    Zhou, D.
    Ning, Z.
    Lu, X.
    ANNALS OF ONCOLOGY, 2015, 26 (08) : 1766 - 1771
  • [36] Efficacy and Safety of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma in the Phase 2 ACE-LY-004 Study
    Wang, Michael
    Rule, Simon
    Zinzani, Pier Luigi
    Goy, Andre
    Casasnovas, Rene-Olivier
    Smith, Stephen D.
    Damaj, Gandhi
    Doorduijn, Jeanette K.
    Lamy, Thierry
    Morschhauser, Franck
    Panizo, Carlos
    Shah, Bijal
    Davies, Andrew
    Eek, Richard
    Dupuis, Jehan
    Jacobsen, Eric
    Kater, Arnon P.
    Le Gouill, Steven
    Oberic, Lucie
    Robak, Tadeusz
    Covey, Todd
    Dua, Richa
    Hamdy, Ahmed
    Huang, Xin
    Izumi, Raquel
    Patel, Priti
    Slatter, J. Greg
    Jurczak, Wojciech
    BLOOD, 2017, 130
  • [37] Camidanlumab Tesirine: Updated Efficacy and Safety in an Open-Label, Multicenter, Phase 2 Study of Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (R/R cHL)
    Carlo-Stella, Carmelo
    Ansell, Stephen
    Zinzani, Pier Luigi
    Radford, John
    Maddocks, Kami
    Pinto, Antonio
    Collins, Graham P.
    Bachanova, Veronika
    Bartlett, Nancy
    Bence-Bruckler, Isabelle
    Hamadani, Mehdi
    Kline, Justin
    Mayer, Jiri
    Savage, Kerry J.
    Advani, Ranjana
    Caimi, Paolo
    Casasnovas, Rene-Olivier
    Feldman, Tatyana
    Hess, Brian
    Bastos-Oreiro, Mariana
    Iyengar, Sunil
    Eisen, Sandy
    Negievich, Yanina
    Wang, Luqiang
    Wuerthner, Jens
    Herrera, Alex F.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S347 - S347
  • [38] A Phase I/II Multicenter, Open-Label Study of the Oral Histone Deacetylase Inhibitor Abexinostat in Relapsed/Refractory Lymphoma
    Evens, Andrew M.
    Balasubramanian, Sriram
    Vose, Julie M.
    Harb, Wael
    Gordon, Leo I.
    Langdon, Robert
    Sprague, Julian
    Sirisawad, Mint
    Mani, Chitra
    Yue, Jeanne
    Luan, Ying
    Horton, Sharon
    Graef, Thorsten
    Bartlett, Nancy L.
    CLINICAL CANCER RESEARCH, 2016, 22 (05) : 1059 - 1066
  • [39] Efficacy and safety of OM-8980 in patients with rheumatoid arthritis: An open-label, long-term, multicenter study
    Bandilla, K
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1999, 60 (12): : 638 - 649
  • [40] AN OPEN-LABEL MULTICENTER STUDY OF GABAPENTIN MONOTHERAPY AND SAFETY IN MEDICALLY REFRACTORY PATIENTS WITH PARTIAL SEIZURES
    HAYES, A
    GREELEY, C
    HES, M
    MANN, M
    GAROFALO, E
    LEIDERMAN, D
    PIERCE, M
    NEUROLOGY, 1995, 45 (04) : A250 - A250
12345